Evidence map›Paper›PMID 35721675›Full record

ArticleHeliyon2022

Data dimensionality reduction technique for clustering problem of metabolomics data.

Rustam, Agus Yodi Gunawan, Made Tri Ari Penia Kresnowati

Abstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

RustamTelkom University, School of Electrical Engineering, Department of Telecommunication Engineering, Jl. Telekomunikasi No.1 Dayeuh Kolot, 40257 Kabupaten Bandung, Jawa Barat, Indonesia.
Agus Yodi GunawanInstitut Teknologi Bandung, Faculty of Mathematics and Natural Sciences, Industrial and Financial Mathematics Research Group, Jl. Ganesha 10 Bandung 40132, Indonesia.
Made Tri Ari Penia KresnowatiInstitut Teknologi Bandung, Faculty of Industrial Technology, Food and Biomass Processing Technology Research Group, Jl. Ganesha 10 Bandung 40132, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In metabolomics studies, independent analyses or replicating the metabolite concentration measurements are often performed to anticipate errors. On the other hand, the size of the dataset is increasing. For clustering purposes, obtaining representative information chemically from independent analyses is needed. The objective of this study is to develop a data reduction method such that a dataset that represents chemical information is obtained. Overall a proper data reduction method would simplify the clustering of metabolite data. We propose the modified Weiszfeld algorithm (MWA) to reduce independent analyses. To obtain comprehensive results, we compare MWA with some other well-known reduction methods, including PCA, CMDS, LE, and LLE. Then reduced datasets are clustered using the fuzzy c-means (FCM) algorithm with the Tang Sun Sun (TSS) index and silhouette index as the cluster validity indices. The results show that MWA, together with PCA, present the optimal number of clusters, namely four clusters. This result aligns with the optimal number of clusters before dimensionality reduction. The present results show that MWA is robust to perform dimensionality reduction of independent analyses while maintaining chemical information on the reduced dataset. Therefore, we recommend the reliability of MWA as one of the chemometric techniques, and the present finding has enriched chemometric techniques in metabolomics studies.

Indexed as

ChemometricDimensionality reductionIndonesian clove budsMetabolite dataMetabolomics

Identifiers

PMID35721675
PMCPMC9201019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.